dc.contributor.author | Bridgett, S | |
dc.contributor.author | Campbell, J | |
dc.contributor.author | Lord, CJ | |
dc.contributor.author | Ryan, CJ | |
dc.date.accessioned | 2017-12-06T12:24:16Z | |
dc.date.issued | 2017-07-26 | |
dc.identifier.citation | Cell systems, 2017, 5 (1), pp. 82 - 86.e3 | |
dc.identifier.issn | 2405-4712 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/963 | |
dc.identifier.eissn | 2405-4720 | |
dc.identifier.doi | 10.1016/j.cels.2017.06.002 | |
dc.description.abstract | Genes whose function is selectively essential in the presence of cancer-associated genetic aberrations represent promising targets for the development of precision therapeutics. Here, we present CancerGD, a resource that integrates genotypic profiling with large-scale loss-of-function genetic screens in tumor cell lines to identify such genetic dependencies. CancerGD provides tools for searching, visualizing, and interpreting these genetic dependencies through the integration of functional interaction networks. CancerGD includes different screen types (siRNA, shRNA, CRISPR), and we describe a simple format for submitting new datasets. | |
dc.format | Print-Electronic | |
dc.format.extent | 82 - 86.e3 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | CELL PRESS | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Cell Line, Tumor | |
dc.subject | Humans | |
dc.subject | Neoplasms | |
dc.subject | Genetic Predisposition to Disease | |
dc.subject | RNA, Small Interfering | |
dc.subject | Gene Expression Profiling | |
dc.subject | Genomics | |
dc.subject | Genotype | |
dc.subject | Systems Integration | |
dc.subject | Software | |
dc.subject | Health Resources | |
dc.subject | Genetic Testing | |
dc.subject | Clustered Regularly Interspaced Short Palindromic Repeats | |
dc.subject | Datasets as Topic | |
dc.subject | Precision Medicine | |
dc.title | CancerGD: A Resource for Identifying and Interpreting Genetic Dependencies in Cancer. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2017-06-08 | |
rioxxterms.versionofrecord | 10.1016/j.cels.2017.06.002 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2017-07-12 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Cell systems | |
pubs.issue | 1 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Gene Function | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Gene Function | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Gene Function | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Gene Function | |
pubs.publication-status | Published | |
pubs.volume | 5 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Gene Function | |
dc.contributor.icrauthor | Campbell, James | |
dc.contributor.icrauthor | Lord, Christopher | |